Arrowhead Pharmaceuticals (ARWR) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Q4 2025 value amounting to $1.81.
- Arrowhead Pharmaceuticals' Times Interest Earned rose 12431.75% to $1.81 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.33, marking a year-over-year increase of 12588.3%. This contributed to the annual value of $1.1 for FY2025, which is 10592.35% up from last year.
- Arrowhead Pharmaceuticals' Times Interest Earned amounted to $1.81 in Q4 2025, which was up 12431.75% from $2.03 recorded in Q3 2025.
- Over the past 5 years, Arrowhead Pharmaceuticals' Times Interest Earned peaked at $17.62 during Q1 2025, and registered a low of -$34.58 during Q2 2024.
- Moreover, its 4-year median value for Times Interest Earned was -$11.07 (2024), whereas its average is -$9.77.
- In the last 5 years, Arrowhead Pharmaceuticals' Times Interest Earned plummeted by 28289.9% in 2024 and then soared by 20112.72% in 2025.
- Over the past 4 years, Arrowhead Pharmaceuticals' Times Interest Earned (Quarter) stood at -$14.79 in 2022, then plummeted by 72.03% to -$25.44 in 2023, then skyrocketed by 70.69% to -$7.46 in 2024, then soared by 124.32% to $1.81 in 2025.
- Its Times Interest Earned stands at $1.81 for Q4 2025, versus $2.03 for Q3 2025 and -$6.79 for Q2 2025.